{"id":"W56664303","doi":"10.1097/01.sla.0000149427.84712.d9","title":"Treatment of Lung Cancer Using Clinically Relevant Oral Doses of the Cyclooxygenase-2 Inhibitor Rofecoxib","year":2005,"lang":"en","type":"article","venue":"Annals of Surgery","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; Merck Canada","keywords":"Rofecoxib; Medicine; Tumor Debulking; Cyclooxygenase; Lung cancer; Chemotherapy; Pharmacology; Internal medicine; Oncology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005509069,0.0001525388,0.0007463163,0.0001041573,0.00003315448,0.000002065864,0.00005626888,0.0001064054,0.000079397],"category_scores_gemma":[0.0003125205,0.00009349854,0.0004933474,0.0001823643,0.0001468248,0.00006464517,0.00002472062,0.00007327592,0.000001658708],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000359362,"about_ca_system_score_gemma":0.0004155724,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002551121,"about_ca_topic_score_gemma":0.00002645278,"domain_scores_codex":[0.9983215,0.0001123861,0.0008553285,0.0001578063,0.0003135448,0.0002394726],"domain_scores_gemma":[0.9982123,0.0005973365,0.0005328657,0.0003404796,0.0002177494,0.00009931481],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001083822,0.000865465,0.8805639,0.0006683387,0.00041541,0.00003066877,0.0004620444,0.0001340696,0.07586218,0.00001699879,0.005286613,0.03461045],"study_design_scores_gemma":[0.0009727969,0.0002776518,0.1955171,0.001110479,0.0002527896,0.00001113467,0.00004052111,0.0007298201,0.7970635,0.000009011245,0.003870027,0.0001451758],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951636,0.002963654,0.000001811597,0.0009315754,0.000526852,0.0002879182,0.00003577433,0.0000107383,0.0000780487],"genre_scores_gemma":[0.997079,0.001976486,0.00009369401,0.0002354162,0.0004762346,0.00001117349,0.000003705283,0.00002078225,0.0001035799],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7212014,"threshold_uncertainty_score":0.381276,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1807599384729389,"score_gpt":0.4065440683657158,"score_spread":0.2257841298927769,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}